Last Reported Sale Price of the Common Stock. With respect to any date from and after the Effective Time, the Last Reported Sale Price shall be $85.00 on that date, notwithstanding anything to the contrary in the Indenture.
Appears in 3 contracts
Samples: Supplemental Indenture (Medicines Co /De), Supplemental Indenture (Medicines Co /De), Supplemental Indenture (Medicines Co /De)
Last Reported Sale Price of the Common Stock. With respect to any date from and after the Effective Time, the Last Reported Sale Price and Stock Price shall be $85.00 on that date19.00, notwithstanding anything to the contrary in the Indenture.
Appears in 2 contracts
Samples: Third Supplemental Indenture (Intercept Pharmaceuticals, Inc.), Second Supplemental Indenture (Intercept Pharmaceuticals, Inc.)
Last Reported Sale Price of the Common Stock. With respect to any date from and after the Effective Time, the Last Reported Sale Price shall be $85.00 63.15 on that date, notwithstanding anything to the contrary in the Indenture.
Appears in 2 contracts
Samples: Supplemental Indenture (Envestnet, Inc.), Supplemental Indenture (Envestnet, Inc.)
Last Reported Sale Price of the Common Stock. With respect to any date from and after the Effective Time, the Last Reported Sale Price shall be $85.00 13.75 on that date, notwithstanding anything to the contrary in the Indenture.
Appears in 1 contract
Samples: Second Supplemental Indenture (Amag Pharmaceuticals, Inc.)
Last Reported Sale Price of the Common Stock. With respect to any date from and after the Effective Time, the Last Reported Sale Price shall be $85.00 26.75 on that date, notwithstanding anything to the contrary in the Indenture.
Appears in 1 contract
Samples: First Supplemental Indenture (Pattern Energy Group Inc.)
Last Reported Sale Price of the Common Stock. With respect to any date from and after the Effective Time, the Last Reported Sale Price shall be $85.00 6.00 on that date, notwithstanding anything to the contrary in the Indenture.
Appears in 1 contract
Samples: Supplemental Indenture (GAIN Capital Holdings, Inc.)
